{
    "root": "360950f4-eef0-54cb-e063-6394a90aa5d6",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "GABAPENTIN",
    "value": "20250526",
    "ingredients": [
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "HYPROMELLOSE 2208 (4000 MPA.S)",
            "code": "39J80LT57T"
        },
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "Gabapentin tablets are indicated for the management of postherpetic neuralgia. \n    Gabapentin tablets are not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration.",
    "contraindications": "Gabapentin tablets should be titrated to an 1,800 mg dose taken orally, once-daily, with the evening meal. Gabapentin tablets should be swallowed whole. Do not crush, split, or chew the tablets. ( 2.1 ) If gabapentin tablets dose is reduced, discontinued, or substituted with an alternative medication, this should be done gradually over a minimum of 1 week or longer (at the discretion of the prescriber). ( 2.1 ) Renal impairment: Dose should be adjusted in patients with reduced renal function. Gabapentin tablets should not be used in patients with CrCl less than 30 or in patients on hemodialysis. ( 2.2 )",
    "warningsAndPrecautions": "Gabapentin tablets are supplied as follows:\n                  \n                     \n                        300 mg tablets:\n                        \n                            \n                        \n                          Gabapentin 300 mg tablets are white color, oval-shaped, film coated tablets debossed with “G5” on one side and “V1” on other side.\n \n  \n                  \n                  \n                  NDC 31722-091-90 (Bottle of 90)\n                  \n                     \n                        600 mg tablets:\n                        \n                          Gabapentin 600 mg tablets are yellow color, oval-shaped, film coated tablets debossed with “G7” on one side and “V1” on other side.\n \n  \n                  \n                  \n                  NDC 31722-092-90 (Bottle of 90) \n  \n                     \n                        Storage\n                     \n                       Store at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted to 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature]. \n    Keep out of reach of children.",
    "adverseReactions": "Gabapentin is contraindicated in patients with demonstrated hypersensitivity to the drug or its ingredients."
}